Role of Erk1/2 activation in prion disease pathogenesis: Absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression
- 7 April 2008
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 196 (1-2) , 16-26
- https://doi.org/10.1016/j.jneuroim.2008.02.009
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agentJournal of Neurochemistry, 2005
- Inhibitors of the Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Pathway Clear Prion-Infected Cells from PrPScJournal of Neuroscience, 2005
- Separate Sequences in a Murine Retroviral Envelope Protein Mediate Neuropathogenesis by Complementary Mechanisms with Differing Requirements for Tumor Necrosis Factor AlphaJournal of Virology, 2004
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- The protein phosphatase 1/2A inhibitor okadaic acid increases CREB and Elk‐1 phosphorylation and c‐fos expression in the rat striatum in vivoJournal of Neurochemistry, 2004
- Endoplasmic Reticulum Stress Is a Determinant of Retrovirus-Induced Spongiform NeurodegenerationJournal of Virology, 2003
- Chronic activation of ERK and neurodegenerative diseasesBioEssays, 2003
- Neuroinflammation in Alzheimer's disease and prion diseaseGlia, 2002
- Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease BrainJournal of Biological Chemistry, 2002
- Induction of apoptosis by Elk-1 and ΔElk-1 proteinsOncogene, 1998